European Cancer Dependency Map Consortium

This consortium provides a forum to align and coordinate DepMap efforts across Europe and with other related initiatives. This initiative not only seeks to advance cancer research but also emphasizes inclusivity in studying diverse cancer models, paving the way for personalized treatment strategies.

Accelerate precision cancer medicine by systematically discovering and understanding cancer dependencies. Over 1,000 cancer models analyzed, yielding unprecedented multi-omics data. Emphasis on larger, complex cancer models, including rare and pediatric cancers. Aim to identify patient-specific vulnerabilities and suitable treatments.

Members